StockData
Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc. (REGN) dividend history

REGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 16/308% above fair value
$955.47+4.28 (+0.45%)

Close on Nov 13, 2026Market cap $98.84BP/E 21.1Yield –

Dividend payments

Every dividend Regeneron Pharmaceuticals has paid, newest first. Shares held at the close of the last day with dividend receive it; shares bought on the ex-dividend date or later do not.

Ex-dividendLast day to buyRecordPayableDeclaredPer shareSource
Nov 20, 2026UpcomingNov 13, 2026Nov 20, 2026Dec 3, 2026–$0.94Release
Aug 18, 2026Aug 17, 2026Aug 18, 2026Aug 31, 2026Jul 30, 2026$0.94Release
May 20, 2026May 19, 2026May 20, 2026Jun 4, 2026Apr 29, 2026$0.94Release
Feb 20, 2026Feb 19, 2026Feb 20, 2026Mar 5, 2026Jan 30, 2026$0.94Release
Nov 20, 2025Nov 19, 2025Nov 20, 2025Dec 5, 2025Oct 28, 2025$0.88Release
Aug 18, 2025Aug 15, 2025Aug 18, 2025Sep 3, 2025Aug 1, 2025$0.88Release
May 20, 2025May 19, 2025May 20, 2025Jun 6, 2025Apr 29, 2025$0.88Release
Feb 20, 2025Feb 19, 2025Feb 20, 2025Mar 20, 2025Feb 4, 2025$0.88Release

Per share as declared at the time. Source document: the dividend announcement filed with the SEC (press release or 8-K) where one exists, otherwise the quarterly or annual report covering the declaration.

See a number that looks wrong?